A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY OF EPALRESTAT (ONO-2235) IN PATIENTS WITH DIABETIC NEUROPATHY

被引：20
|
作者：
GOTO, Y [1 ]
HOTTA, N [1 ]
SHIGETA, Y [1 ]
SAKAMOTO, N [1 ]
KITO, S [1 ]
MATSUOKA, K [1 ]
TAKAHASHI, A [1 ]
KIKKAWA, R [1 ]
SAKUMA, A [1 ]
机构：
[1] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 3,65 TSURUMAI CHO,SHOWA KU,NAGOYA,AICHI 466,JAPAN
来源：
DIABETIC MEDICINE | 1993年 / 10卷 / 05期
关键词：
ALDOSE REDUCTASE INHIBITOR; CLINICAL TRIALS; DIABETIC NEUROPATHY; EPALRESTAT; HEMOGLOBIN A1C; NERVE CONDUCTION VELOCITY;
D O I：
10.1111/j.1464-5491.1993.tb00197.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S39 / S43
页数：5
相关论文
共 50 条
  • [1] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, EPALRESTAT, ON DIABETIC NEUROPATHY - CLINICAL BENEFIT AND INDICATION FOR THE DRUG ASSESSED FROM THE RESULTS OF A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
    GOTO, Y
    HOTTA, N
    SHIGETA, Y
    SAKAMOTO, N
    KIKKAWA, R
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (06) : 269 - 277
  • [2] Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study
    Rowbotham, MC
    Goli, V
    Kunz, NR
    Lei, D
    PAIN, 2004, 110 (03) : 697 - 706
  • [3] Lacosamide in painful diabetic peripheral neuropathy - A phase 2 double-blind placebo-controlled study
    Rauck, Richard L.
    Shaibani, Aziz
    Biton, Victor
    Simpson, Jqff
    Koch, Brigitte
    CLINICAL JOURNAL OF PAIN, 2007, 23 (02) : 150 - 158
  • [4] CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY
    HEIMANS, JJ
    DRUKARCH, B
    MATTHAEI, I
    IJFF, GA
    BERTELSMANN, FW
    STRIJERS, RLM
    NAUTA, J
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (06): : 483 - 486
  • [5] Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy: A long-term, randomised, double-blind, placebo-controlled study
    De Grandis D.
    Minardi C.
    Drugs in R & D, 2002, 3 (4) : 223 - 231
  • [6] Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: A preliminary study
    Fujishima, H
    Shimazaki, J
    Yagi, Y
    Tsubota, K
    CORNEA, 1996, 15 (04) : 368 - 372
  • [7] GANGLIOSIDES IN THE TREATMENT OF DIABETIC NEUROPATHY - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY
    LINGETTI, M
    COTO, V
    RENGO, F
    SGAMBATO, S
    INNOCENTI, A
    FIORI, MG
    DIABETES NUTRITION & METABOLISM, 1992, 5 (04) : 275 - 282
  • [8] Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study
    Agrawal, R. P.
    Goswami, Jitender
    Jain, Shreyans
    Kochar, D. K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (03) : 371 - 378
  • [9] Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study
    Dogra, S
    Beydoun, S
    Mazzola, J
    Hopwood, M
    Wan, Y
    EUROPEAN JOURNAL OF PAIN, 2005, 9 (05) : 543 - 554
  • [10] A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy
    Grosskopf, J.
    Mazzola, J.
    Wan, Y.
    Hopwood, M.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (03): : 177 - 180
12345